AngioDynamics (ANGO) Tops Q3 EPS by 14c ; Offers Guidance

AngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.03, $0.14 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $72 million versus the consensus estimate of $70.57 million.

GUIDANCE:

AngioDynamics sees FY2025 EPS of ($0.31)-($0.34), versus the consensus of ($0.35). AngioDynamics sees FY2025 revenue of $285-288 million, versus the consensus of $284.9 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders
• Nuvectis Pharma (NVCT) files $200M mixed shelf